一种使用切除和细胞静止剂治疗易斯肺癌组合疗法的模型
N N Ermakova1, E G Skurikhin2, I L Zharkikh2
1Institute of General Pathology and Pathophysiology, Moscow, Russia. nejela@mail.ru.
Bulletin of experimental biology and medicine
|February 14, 2025
概括
这项研究为小鼠的易斯肺癌 (LLC) 提供了一种组合治疗模式,将瘤切除与化疗相结合. 这种方法改善了生存率,尽管在某些情况下出现了化学抵抗.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 临床前模型 临床前模型
背景情况:
- 易斯肺癌 (LLC) 是研究肺癌进展和治疗疗效的常见模型.
- 转移和化学抵抗仍然是肺癌治疗中的重大挑战.
研究的目的:
- 开发和评估易斯肺癌 (LLC) 的综合治疗模式,包括手术切除和化疗.
- 在临床前小鼠模型中评估这种联合治疗在减少转移和改善存活率方面的有效性.
主要方法:
- 在C57BL/6小鼠中注射LLC细胞,以确定原发性瘤和肺转移.
- 初级瘤的手术切除是在注射后的第8天进行的.
- 小鼠接受了两次卡博普拉丁和帕克利塔塞尔的腹腔内注射,用于化疗.
- 监测了瘤生长,转移,存活率和化学抵抗的出现.
主要成果:
- 与单一疗法相比,组合疗法 (切除+化疗) 显著降低了转移和死亡率.
- 这种综合方法改善了LLC的小鼠60%的存活率.
- 化学抵抗在40%的小鼠中发生,其特点是抑制指数下降和循环癌症干细胞的存在.
结论:
- 瘤切除和化疗的组合模型为LLC提供了增强的抗瘤和抗转移效应.
- 化学抵抗和癌症干细胞的出现凸显了这种综合方法的关键挑战.
- 这种临床前模型为开发新型肺癌治疗策略提供了宝贵的平台.
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463


